Drug intelligence / Profile preview

aloe polymannose

Development stage: Preclinical
Administration: Oral

Overview

Aloe polymannose is a polysaccharide derived from aloe, which is a key ingredient in an aloe polymannose multinutrient complex (APMC). This complex has been investigated as a dietary supplement for its potential to improve cognitive function in individuals with moderate to severe Alzheimer's dementia. The proposed mechanism of action involves the modulation of brain-derived neurotrophic factor (BDNF) levels, which are crucial for neurosynaptic function, learning, and memory. Clinical studies have shown modest improvements in cognitive outcomes and correlations between cognitive functioning and BDNF levels after supplementation with the APMC.

Other names: aloe polymannose multinutrient complex

Targets

BDNF (Brain-derived neurotrophic factor)

Beyond the preview

Go deeper on aloe polymannose.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on aloe polymannose.

Explore the full profile